Sumatriptan ne uzrokuje znacajnu mozdanu vazokonstrikciju u migreni

Neurologia Croatica

Volumn 48, Issue 2-3, 1999, Pages 119-126

  Lovrencic Huzjan A ^a   Demarin, V ^a   Malic M ^a  

^a SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33544470228     PISSN: 03538842     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Aaslid R, ed. Transcranial Doppier Sonography. New York: Springer-Verlag, 1986.
2. Aaslid R, Markwalder TM, Nornes H. Noninvasive Transcranial Doppier ultrasoundrecording of flow velocity in basal cerebral arteries. J Neurosurg 1982; 57: 769-774.
3. Andersson JLR, Muhr C, Lilja A, Valind S, Lundberg PO, Langstrom B. Regional cerebral blood flow and oxygen metabolism during migraine with and without aura. Cephalalgia 1997; 17: 570-579.
4. Bishop CCR, Powell S, Rutt D et al. Transcranial Doppler measurement of middle cerebral artery blood flow velocity. Stroke 1986; 17: 913-915.
5. Bregoni M, Feldmann E. Transcranial Doppler indices of intracranial hemodynamics. In: Tegler CH, Babikian VL, Gomez CR, eds. Neurosonology. St. Louis: Mosby 1996; 129-139.
6. Buzzi MG, Moskowitz MA. The antimigraine drug, sumatriptan (GR 43175), specifically blocks neurogenic plasma extravasation from blood vessels in dura mater. Br J Pharmacol 1990; 99: 202-206.
7. Caekebeke JFV, Ferrari MD, Zwetsloot CP, Jansen J, Saxena PR. Antimigraine drug sumatriptan increases blood flow velocity in large cerebral arteries during migraine attacks. Neurology 1992; 42:1522-1526.
8. Dahlöf CGH, Mathew N. Cardiovascular safety of SHT Ib/lD agonists - is there a cause for concern? Cephalalgia 1998; 18: 539-545.
9. Demarin V, Lovrencic-Huzjan A, Rundek T, Podobnik-Sarkanji S. Pharmacotherapy of migraine. Acta Clin Croat 1995; 34t 81-89.
10. Demarin V, Rundek T, Podobnik-Sarkanji S, Lovrencic-Huzjan A. A correlation of 5 hydroxytriptamine and cerebral vasoreactivity in patients with migraine. Funct Neurol 1994; 9: 235-245.
11. Demarin V, ed. Mozdani krvotok-klinicki pristup. Zagreb: Naprijed, 1994.
12. Diener HC, Peters C, Rudzio M, Noe A, Dichgans J, Haux R, Ehrmann R, Tfelt-Hansen P. Ergotamine, flunarizine and sumatriptan do not change cerebral blood flow velocity in normal subjects and migraineurs. J Neurol 1991; 238: 245-250.
13. Diener HC. Positron emission tomography studies in headache. Headache 1997; 37: 622-625.
14. Ferrari MD, Haan J, Blokland JAK, Arndt JW, Minnee P, Zwinderman AH, Pauwels EKJ, Saxena PR. Cerebral blood flow during migraine attacks without aura and effect of sumatriptan. Arch Neurol 1995; 52:135-139.
15. Friberg L, Olesen J, Iversen HK, Sperling B. Migraine pain associated with middle cerebral artery dilatation: reversal by sumatriptan. Lancet 1991; 338:13-17.
16. Gossling RG, King DH. Arterial assessment by Doppler-shift ultrasound. Proc R Soc Med 1974; 67:447-449.
17. Headache Classification Committee of the International Headache Society Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988; 8 (Suppl 7): 1-96.
18. Henkes H, May A, Kühne D, Berg-Dammer E, Diener HC. Sumatriptan: vasoactive effect on human durai vessels, demonstrated by subselective angiography. Cephalalgia 1996; 16: 224-230.
19. Jansen J, Edvinsson L, Mortensen A, Olesen J. Sumatriptan is a potent vasoconstrictor of human durai arteries via a 5HTl-like receptor. Cephalalgia 1992;12:202-205.
20. Limmroth V, May A Auerbach P, Wosnitza G, Eppe T, Diener HC. Changes in cerebral blood flow velocity after treatment with sumatriptan or placebo and implications for the pathophysiology of migraine. J Neurol Sei 1996; 138 : 60-65.
21. Lovrencic-Huzjan A, Demarin V, Rundek T, Serie V. Cerebral haemodynamic changes during a migraine attack. Period Biol 1995; 97:127-132.
22. Rundek T, Demarin V, Kittner B. Impairment of cerebral vasoreactivity (CVR) inpatients with multi-infarct dementia. Acta Clin Croat 1993; 51-59.
23. Seiler RW, Aaslid R. Subarachnoid hemorrhage and vasospasm. In: Newel DW, Aaslid R, eds. Transcranial Doppier. New York: Raven Press, 1992:101-108.
24. White LR, Sjaastad O. Sumatriptan and sensory neuropeptide activity in subarachnoid haemorrhage: a hypothesis. Cephalalgia 1995; 15: 470-471.
25. Zanette EM, Agnoli A, Roberti C, Chiarotti F, Cerbo R, Fieschi C. Transcranial Doppler in spontaneous attacks of migraine. Stroke 1992; 23: 680-685.